EASIX predicts non-relapse mortality after haploidentical transplantation with post-transplant cyclophosphamide-Reference-Cited by-同舟云学术

EASIX predicts non-relapse mortality after haploidentical transplantation with post-transplant cyclophosphamide

Published:2022-11-21 Issue:3 Volume:58 Page:247-256
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Mariotti Jacopo^ORCID,Magri Filippo,Giordano Laura,De Philippis Chiara^ORCID,Sarina Barbara,Mannina Daniele,Taurino Daniela,Santoro Armando^ORCID,Bramanti Stefania^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-022-01874-5.pdf

Reference41 articles.

1. Pagliuca S, Michonneau D, Sicre de Fontbrune F, Sutra Del Galy A, Xhaard A, Robin M. et al. Allogeneic reactivity-mediated endothelial cell complications after HSCT: a plea for consensual definitions. Blood Adv. 2019;3:2424–35. https://doi.org/10.1182/bloodadvances.2019000143.

2. Penack O, Henke E, Suh D, King CG, Smith OM, Na IK, et al. Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth. J Natl Cancer Inst. 2010;102:894–908. https://doi.org/10.1093/jnci/djq172.

3. Fan CQ, Crawford JM. Sinusoidal obstruction syndrome (hepatic veno-occlusive disease). J Clin Exp Hepatol. 2014;4:332–46.

4. Gloude NJ, Khandelwal P, Luebbering N, Lounder DT, Jodele S, Alder MN, et al. Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD. Blood. 2017;130:1259–66. https://doi.org/10.1182/blood-2017-05-782870.

5. Xie Z, Ghosh CC, Patel R, Iwaki S, Gaskins D, Nelson C, et al. Vascular endothelial hyperpermeability induces the clinical symptoms of Clarkson disease (the systemic capillary leak syndrome). Blood. 2012;119:4321–32. https://doi.org/10.1182/blood-2011-08-375816.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surrogates of Endothelial Injury Predict Survival After Post-transplant Cyclophosphamide;Transplantation and Cellular Therapy;2024-08

2. Allogeneic transplantation after immunotherapy for relapsed/refractory non-Hodgkin lymphoma: a comparison with a historical cohort;Cytotherapy;2024-05

3. EASIX and cardiac adverse events after allogeneic hematopoietic cell transplantation;Bone Marrow Transplantation;2024-03-23

4. Easix Score Correlates With Endothelial Dysfunction Biomarkers and Predicts Risk of Acute Graft-Versus-Host Disease After Allogeneic Transplantation;Transplantation and Cellular Therapy;2024-02

5. Endothelial Activation and Stress Index in adults undergoing allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based prophylaxis;Cytotherapy;2024-01